RxDoctor Payments Data

Barry Coller

Hematology · New York, NYNPI 1043227416

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $7,926,291 of the $7,929,521 with a category attached, or 100.0%. Instrumentation Laboratory Company accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $1,400,974 and has fallen 95.5% since, to $62,787 in 2025. Among hematology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,929,521in general payments, 2019–2025

Across 23 payments — averaging $344,762 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Instrumentation Laboratory Company$7.9M
  • Chugai Pharmaceutical Co., Ltd.$3K

What the payments were for

  • Royalty or licence$7,926,291100%
  • Consulting fees$3,2300%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,929,521 in reported general payments places this provider in the 95th percentile of 157 hematology providers in New York.

See all hematology providers in New York →

Other hematology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →